{"transactions":[{"id":3782546,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option","published_at":"2018-10-26T20:17:16.000Z","date":"2018-10-16","kind":"other","acquired":false,"shares":352000,"price":0.2,"value":70400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person assigned 352,000 to a third party as consideration for consulting services."}],"balance_after":2697500,"derivative":{"exercise_price":0.2,"exercise_date":"2018-10-16","expiration_date":"2023-10-12","underlying":"Common Stock, par value $0.01","underlying_shares":352000},"source":{"system":"sec-edgar","filing":"0001213900-18-014504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018014504/ownership.xml","form_type":"4"}},{"id":4049019,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":31410,"price":0.23,"value":7224.3,"ownership":{"direct":false,"nature":"Faith McLaughlin - Daughter"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":506781,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049018,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":96593,"price":0.23,"value":22216.39,"ownership":{"direct":false,"nature":"Faith McLaughlin - Daughter"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":538191,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049017,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"disposition_to_issuer","acquired":false,"shares":217391,"price":0.23,"value":49999.93,"ownership":{"direct":false,"nature":"Faith McLaughlin - Daughter"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":634784,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049016,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":31582,"price":0.23,"value":7263.86,"ownership":{"direct":false,"nature":"Mark McLaughlin Jr. - Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":506780,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049015,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"disposition_to_issuer","acquired":false,"shares":217391,"price":0.23,"value":49999.93,"ownership":{"direct":false,"nature":"Mark McLaughlin Jr. - Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":538362,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049014,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":31504,"price":0.23,"value":7245.92,"ownership":{"direct":false,"nature":"James McLaughlin - Son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":506780,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049013,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":15000,"price":0.23,"value":3450.0,"ownership":{"direct":false,"nature":"James McLaughlin - Son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":538284,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049012,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"disposition_to_issuer","acquired":false,"shares":217391,"price":0.23,"value":49999.93,"ownership":{"direct":false,"nature":"James McLaughlin - Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":553284,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049011,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":5504,"price":0.23,"value":1265.92,"ownership":{"direct":false,"nature":"Genevieve McLaughlin - Daughter"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":506780,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049010,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"disposition_to_issuer","acquired":false,"shares":217391,"price":0.23,"value":49999.93,"ownership":{"direct":false,"nature":"Genevieve McLaughlin - Daughter"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":512284,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049009,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":190000,"price":0.23,"value":43700.0,"ownership":{"direct":false,"nature":"Bruni McLaughlin - Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":54228,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049008,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":false,"nature":"McLaughlin International, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Persons beneficially owns shares through a company owned together with his spouse."}],"balance_after":1040000,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049007,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":298407,"price":0.23,"value":68633.61,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement."}],"balance_after":2342100,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}},{"id":4049006,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":162763,"kind":"person","name":"McLaughlin Mark","position":1,"cik":"0001721526","reported_name":"McLaughlin Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2018-02-21T01:00:08.000Z","date":"2018-02-13","kind":"disposition_to_issuer","acquired":false,"shares":1130436,"price":0.23,"value":260000.28,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share."}],"balance_after":2640507,"source":{"system":"sec-edgar","filing":"0001213900-18-002139","document":"f4021318mclaughlin_immudyne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000121390018002139/f4021318mclaughlin_immudyne.xml","form_type":"4"}}]}